Anticoagulation control of warfarin in anticoagulation medication therapy adherence clinics

Abstract Background Warfarin therapy remains essential in anticoagulation management and its quality is measured by the time in therapeutic range (TTR). In Malaysia, some healthcare centres provide the Anticoagulation Medication Therapy Adherence Clinic (ACMTAC) service for warfarin management, which is managed by pharmacists. Aim To evaluate overall TTR and to analyse the occurrence of thromboembolic and bleeding complications in warfarin patients. Method This cross‐sectional, retrospective cohort study included patients who received warfarin treatment over a 3‐year period (2019–2021). Data were collected from 49 healthcare centres in Malaysia with ACMTAC services. TTR was calculated using the Rosendaal method from international normalised ratio (INR) data acquired across these centres. TTR ≥ 65% was defined as good control of anticoagulation therapy. Ethical approval was granted by the Medical Research and Ethics Committee, Ministry of Health Malaysia (Reference no: NMRR‐ 21‐779‐59275) and the study conforms with the Declaration of Helsinki. Results The mean age (±standard deviation [SD]) of the 1464 included patients was 60.3 (±13.1) years, and 732 (50.0%) were male. Atrial fibrillation (65.7%) and valve replacement (23.1%) were the main indications for warfarin therapy. From 2019 to 2021, the annual mean TTR (±SD) were 63.1% (±24.5%), 64.0% (±25.0%), and 64.1% (±26.3%) respectively. For three consecutive years, more than 49% of patients achieved good control of anticoagulation therapy. Among the 49 centres, over 24 (49.0%) achieved a mean TTR of ≥65%, and the mean TTR varied significantly between centres (p < 0.001). The occurrence of bleeding and thromboembolic events was 227 (15.5%) and 15 (1.0%) respectively. Conclusion In Malaysia, the anticoagulation control of warfarin under ACMTAC management is moderate, with about half of patients demonstrating good control levels. Over a 3‐year observation period, there was variation in TTR among the centres.

Authors

Institutions

Publication Details

Journal
Journal of Pharmacy Practice and Research
Published
2025-02-05
DOI
https://doi.org/10.1002/jppr.1965
Citations
1
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
1.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Anticoagulation control of warfarin in anticoagulation medication therapy adherence clinics

N.A. Nik-Ismail, Sahimi Mohamed, Wardati Mazlan‐Kepli, Jivanraj R‐Nagarajah
1 citations
Journal of Pharmacy Practice and Research
Atrial Fibrillation Management and Outcomes
1.39
article

Anticoagulation control of warfarin in anticoagulation medication therapy adherence clinics

N.A. Nik-Ismail, Sahimi Mohamed, Wardati Mazlan‐Kepli, Jivanraj R‐Nagarajah
article en
1 citations

Abstract

Abstract Background Warfarin therapy remains essential in anticoagulation management and its quality is measured by the time in therapeutic range (TTR). In Malaysia, some healthcare centres provide the Anticoagulation Medication Therapy Adherence Clinic (ACMTAC) service for warfarin management, which is managed by pharmacists. Aim To evaluate overall TTR and to analyse the occurrence of thromboembolic and bleeding complications in warfarin patients. Method This cross‐sectional, retrospective cohort study included patients who received warfarin treatment over a 3‐year period (2019–2021). Data were collected from 49 healthcare centres in Malaysia with ACMTAC services. TTR was calculated using the Rosendaal method from international normalised ratio (INR) data acquired across these centres. TTR ≥ 65% was defined as good control of anticoagulation therapy. Ethical approval was granted by the Medical Research and Ethics Committee, Ministry of Health Malaysia (Reference no: NMRR‐ 21‐779‐59275) and the study conforms with the Declaration of Helsinki. Results The mean age (±standard deviation [SD]) of the 1464 included patients was 60.3 (±13.1) years, and 732 (50.0%) were male. Atrial fibrillation (65.7%) and valve replacement (23.1%) were the main indications for warfarin therapy. From 2019 to 2021, the annual mean TTR (±SD) were 63.1% (±24.5%), 64.0% (±25.0%), and 64.1% (±26.3%) respectively. For three consecutive years, more than 49% of patients achieved good control of anticoagulation therapy. Among the 49 centres, over 24 (49.0%) achieved a mean TTR of ≥65%, and the mean TTR varied significantly between centres (p < 0.001). The occurrence of bleeding and thromboembolic events was 227 (15.5%) and 15 (1.0%) respectively. Conclusion In Malaysia, the anticoagulation control of warfarin under ACMTAC management is moderate, with about half of patients demonstrating good control levels. Over a 3‐year observation period, there was variation in TTR among the centres.

Journal of Pharmacy Practice and ResearchVol. 55(4)
Ministry of Health (MY), Serdang Hospital (MY), Hospital Kuala Lumpur (MY), University of Malaya (MY), Hospital Raja Perempuan Zainab II (MY)
Openalex Percentile: Top 23%
Atrial Fibrillation Management and Outcomes
1.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.